From Medscape Pathology

European Society of Gene and Cell Therapy (ESGCT) 2016 Annual Congress

October 18 - 21, 2016; Florence, Italy

October 18 - 21, 2016 Florence, Italy

ESGCT Scientists Debate Ethics of In Utero Germline Editing As technology and the field of germline editing move forward, ethical concerns are being raised about altering the human genome.
Medscape Medical News, October 31, 2016
ESGCT New CRISPR Tools More Precise, but Targeting Mishaps a Worry A new cutting tool in the CRISPR toolbox provides a greater range of precision and efficiency, but it can also result in off-target gene mutations with unknown and unintended consequences.
Medscape Medical News, October 25, 2016

Gene Therapy Is 'Becoming a Clinical Reality' After setbacks that included leukemia in treated patients, there is now enthusiasm for a new approach to gene therapy using lentiviral vectors.
Medscape Medical News, Dec 17, 2015
Hepatocyte Growth Factor Shows Benefit for Diabetic Pain The nonviral gene therapy shows higher efficacy in pain relief among patients not taking pregabalin or gabapentin.
Medscape Medical News, Oct 9, 2015
Gene Editing Trials Poised to Expand, but Hurdles Remain Few gene editing applications are in clinical trials, but that may change in 2016, as researchers sharpen the tools and companies tackle new targets.
Medscape Medical News, Nov 30, 2015

Medscape Pathology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Previous Coverage

Related Resource